Armata Pharmaceuticals (ARMP) Income from Continuing Operations (2016 - 2026)
Quarterly results put Income from Continuing Operations at 14344000.0 for Q1 2026, down 21.63% from a year ago — trailing twelve months through Mar 2026 was 55775000.0 (down 5.83% YoY), and the annual figure for FY2025 was 53224000.0, changed 0.09%.
Armata Pharmaceuticals has reported Income from Continuing Operations over the past 14 years, most recently at 14344000.0 for Q1 2026.
- Income from Continuing Operations reached 14344000.0 in Q1 2026 per ARMP's latest filing, up from 18657000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8614000.0 in Q3 2022 and bottomed at 18657000.0 in Q4 2025.
- Median Income from Continuing Operations over the past 5 years was 11465000.0 (2023), compared with a mean of 11807470.59.
- The largest annual shift saw Income from Continuing Operations tumbled 70.56% in 2022 before it rose 26.08% in 2025.
- Over 5 years, Income from Continuing Operations stood at 10314000.0 in 2022, then dropped by 6.27% to 10961000.0 in 2023, then decreased by 26.07% to 13819000.0 in 2024, then tumbled by 35.01% to 18657000.0 in 2025, then grew by 23.12% to 14344000.0 in 2026.
- Business Quant data shows Income from Continuing Operations for ARMP at 14344000.0 in Q1 2026, 18657000.0 in Q4 2025, and 12122000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -8.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -14.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.34 Mn |
| Dec 31, 2025 | -18.66 Mn |
| Sep 30, 2025 | -12.12 Mn |
| Jun 30, 2025 | -10.65 Mn |
| Mar 31, 2025 | -11.79 Mn |
| Dec 31, 2024 | -13.82 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -14.41 Mn |
| Mar 31, 2024 | -12.00 Mn |
| Dec 31, 2023 | -10.96 Mn |
| Sep 30, 2023 | -11.47 Mn |
| Jun 30, 2023 | -9.58 Mn |
| Mar 31, 2023 | -11.33 Mn |
| Dec 31, 2022 | -10.31 Mn |
| Sep 30, 2022 | -8.61 Mn |
| Jun 30, 2022 | -9.22 Mn |
| Mar 31, 2022 | -8.77 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | -6.15 Mn |
| Jun 30, 2021 | -6.19 Mn |
| Mar 31, 2021 | -5.50 Mn |
| Dec 31, 2020 | -6.55 Mn |
| Sep 30, 2020 | -5.77 Mn |
| Jun 30, 2020 | -4.71 Mn |
| Mar 31, 2020 | -5.08 Mn |
| Dec 31, 2019 | -4.59 Mn |
| Sep 30, 2019 | -6.96 Mn |
| Jun 30, 2019 | -4.20 Mn |
| Mar 31, 2019 | -3.70 Mn |
| Dec 31, 2018 | -1.10 Mn |
| Sep 30, 2018 | -2.77 Mn |
| Jun 30, 2018 | -3.17 Mn |
| Mar 31, 2018 | -3.06 Mn |
| Dec 31, 2017 | 4.85 Mn |
| Sep 30, 2017 | -779,000.00 |
| Jun 30, 2017 | -6.46 Mn |
| Mar 31, 2017 | -3.36 Mn |
| Dec 31, 2016 | 2.98 Mn |
| Sep 30, 2016 | -2.38 Mn |
| Jun 30, 2016 | -3.85 Mn |